5001PCSK9-Inhibitor treatment of cardiovascular high risk patients in a real-world setting. (28th August 2018) - Kassner, U; Hollstein, T; Grenkowitz, T; Scharnagl, H; Maerz, W; Steinhagen-Thiessen, E